Everen Specialty Appoints Carla Greaves Chief Underwriting Officer
Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425273777/en/
Carla Greaves
Ms. Greaves will join the Executive Leadership Team of the Everen Group, based in the Bermuda office, later this year. She succeeds Jane Peterson, Interim CUO, who will continue in a consultancy capacity to facilitate the transition.
With more than 30 years of underwriting and leadership experience in the (re)insurance industry, Ms. Greaves brings a wealth of expertise and a proven track record of success in the Casualty market where she is recognized for building high-performing teams, driving profitable growth, and successfully navigating complex market environments.
Prior to joining Everen Specialty, Ms. Greaves held increasingly senior leadership positions, most recently serving as Global CUO for Casualty at AXA XL in Bermuda.
“We are delighted to welcome Carla to the Everen Group,” said Robert Foskey, President & CEO of the Everen Group. “Carla is widely respected in the industry as an outstanding and experienced leader with deep technical expertise and a passion for building high-performing teams. Her proven leadership will be instrumental as we develop and execute on our new three-year strategic plan for Everen Specialty – strengthening our underwriting capabilities and continuing to deliver a world-class service to our members and policyholders.”
He added: "Her appointment as CUO marks an exciting new chapter for Everen Specialty and underscores our commitment to providing stable energy insurance capacity for our members and policyholders for the long term. We look forward to the considerable experience and leadership Carla will bring to our business.”
Ms. Greaves commented: “I’m honored to join Everen Specialty at such a pivotal time. I look forward to working with the team to enhance underwriting performance, support the new strategy, and continue providing exceptional service to members and policyholders.”
Ms. Greaves holds a degree in Business Administration and Management from the Peter J. Tobin College of Business at St. John’s University, as well as a professional designation from the Chartered Insurance Institute.
About Everen Group:
The Everen Group – a group of leading energy insurance companies based in Bermuda – includes two distinct operating companies providing complementary products: Everen and Everen Specialty. Everen is the largest energy insurance mutual company in the world, operating for over 50 years and acting as a pure mutual owned by its member shareholders. Its underwriting is 100% supported by its own balance sheet with no third-party capital and it offers up to $450 million of per occurrence limits. Everen Specialty is an industry owned commercial (re)insurer offering property and casualty insurance and reinsurance for members and non-members. Everen Specialty also has a subsidiary, OCIL Specialty, Ltd (OSL), writing U.S. surplus lines business through OSL Insurance Services (OISI), a managing general agent based in Houston, Texas.
For further information about the Everen Group, please visit www.everengroup.bm
View source version on businesswire.com: https://www.businesswire.com/news/home/20250425273777/en/
Contacts
For inquiries regarding this press release, please contact Elizabeth Deacon,
Communications Manager at elizabeth.deacon@everengroup.bm
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Mirakl-Storfund Partnership Offers Businesses Improved Cash Flow on 400+ Marketplaces13.5.2025 09:00:00 CEST | Press Release
Storfund has announced a new partnership that will enable businesses to use the fintech’s cash flow solution on the 400+ marketplaces powered by Mirakl, the leading provider of ecommerce software solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513755226/en/ New Mirakl X Storfund partnership launches The solution, called Daily Advance, is the first financing product to be embedded on Mirakl Connect. Designed to eliminate the standard delay of 25 days between sale and payout, Daily Advance will see Storfund pay businesses as soon as they ship their goods, improving their cash flow and supporting their growth. The service will be available on marketplaces globally including Macy’s, Nordstrom, Best Buy, B&Q, Decathlon and Carrefour. The deal comes a few months after Storfund’s launch on TikTok Shop, a partnership which has already seen Storfund finance tens of millions in sales to US sellers. The new partnership wit
TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans13.5.2025 08:00:00 CEST | Press Release
TreeFrog Therapeutics, a French biotech specializing in cell therapy is the first company to present a clinical-ready delivery strategy for 3D microtissues cell therapy. The validated approach was demonstrated for their 3D neural microtissues cell therapy treatment for Parkinson’s disease. Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a progressive disease characterized by the loss of dopaminergic neurons with a mix of motor symptoms (bradykinesia, rigidity, resting tremor) and non-motor symptoms (cognitive deficits, mood disorders, fatigue). Current treatments provide symptomatic relief only. There is a huge unmet need with a prevalence that has doubled in the last 25 years to an estimated 10 million sufferers, and it is expected to double again by 20501,2. Research into cell replacement strategies for Parkinson’s disease has been ongoing for decades and the promise of cell therapy in the disease has resulted in a dynamic cli
Ohana Development Launches ‘Jacob & Co. Beachfront Living by Ohana,’ A Masterpiece of Beachfront Elegance in the UAE13.5.2025 08:00:00 CEST | Press Release
Ohana Development, the leading real estate developer renowned for its luxury properties, has launched ‘Jacob & Co. Beachfront Living by Ohana’ in partnership with luxury timepiece and jewellery house Jacob & Co. The project was revealed at Emirates Palace Mandarin Oriental, Abu Dhabi. Located in Al Jurf between Dubai and Abu Dhabi, this USD 1.3 billion development blends natural surroundings with exceptional artistry and craftsmanship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512533615/en/ Jacob & Co. Beachfront Living by Ohana. (Photo: AETOSWire) Jacob & Co. Beachfront Living by Ohana presents 457 residences comprising of sea-view apartments, villas, penthouses, Sky Mansions, and beachfront mansions—each capturing the spirit of refined coastal living. Penthouses, starting from USD 6 million, feature 180-degree vistas and expansive interiors, while Sky Mansions, starting from USD 21 million, offer 360-degree panoram
Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders13.5.2025 07:00:00 CEST | Press Release
Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of an oversubscribed €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and with additional participation from Seroba, Pictet Group and existing investors Forbion Ventures, Schroders Capital and BioGeneration Ventures (BGV). This financing enables Azafaros to accelerate the development of its lead product nizubaglustat, scheduled to enter Phase 3 studies for Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses later this year, as well as expanding the Azafaros pipeline to other indications. Rachel Mears, Partner at Jeito Capital; Julien Elric, Senior Principal at Jeito Capital; and Audrey Cacaly, Principal at Forbion Growth will also join Azafaros’s Board of Directors as Board members. Founded in 2018 by BGV, leveraging science from Leiden University and Amsterdam U
Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner12.5.2025 19:04:00 CEST | Press Release
Christian brings more than 20 years of global experience in investment banking, private equity, and operational leadership, with a proven track record of driving transformational growth across industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512473756/en/ Christian Schütte Christian began his career at J.P. Morgan in New York and London, where he worked in the M&A and Corporate Finance teams. He later joined Fortress Investment Group and was instrumental in launching its German operations. During his tenure, he helped raise over €1.5 billion in equity and managed a wide array of investments, including non-performing and performing loans, private and public companies. He went on to join EQT Group, where he focused on mid-market growth and succession investments. Notably, he led the consolidation of nine digital marketing agencies into a €100 million market leader, building one of the most comprehensive digital ma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom